Transparency as a Double-Edged Sword: Public Health Ethics Perspective
Article Sidebar
Main Article Content
Abstract
Transparency has gained much attention in both public health and medical contexts. Alberto Giubilini, Rachel Gur-Arie and Euzebiusz Jamrozik make a valuable contribution to addressing the ethical question on the value and role of transparency by claiming that transparency is a necessary condition for the moral trustworthiness of experts. This comment is conceived as a follow-up on this issue. Usually, ethical discussions on transparency concern its consequentialist aspects such as the influence of disclosure on stakeholders’ trust. However, as the author will claim, there is something morally significant and non-consequentialist at stake. The aim of the comment is to highlight two important aspects concerning transparency. Firstly, its role in public health ethics, and, secondly, the moral basis for this role. Regarding the former, the author will claim that transparency influences moral legitimacy of coercive public health policies. Regarding the latter, the author will claim that by being transparent, policymakers respect stakeholders as moral agents capable of reason.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting his/her work to the Editorial Board, the author accepts, upon having his/her text recommended for publication, that Diametros applies the Attribution 4.0 International (CC BY 4.0) license to the works we publish. Under this license, authors agree to make articles legally available for reuse, without permission or fees. Anyone may read, download, copy, print, distribute or reuse these articles without asking prior permission from the publisher or the author, as long as the author and original source are properly cited. The author holds the copyright without any other restrictions. Full information about CC-BY: https://creativecommons.org/licenses/by/4.0/legalcode.
How to Cite
References
Bardosh K., de Figueiredo A., Gur-Arie R., Jamrozik E., Doidge J., Lemmens T., Keshavjee S., Graham J.E., Baral S. (2022a), “The Unintended Consequences of COVID-19 Vaccine Policy: Why Mandates, Passports and Restrictions May Cause More Harm than Good,” BMJ Global Health 7 (5): 1–14.
Bardosh K., Krug A., Jamrozik E., Lemmens T., Keshavjee S., Prasad V., Makary M.A., Baral S., Høeg T.B. (2022b), “COVID-19 Vaccine Boosters for Young Adults: A Risk Benefit Assessment and Ethical Analysis of Mandate Policies at Universities,” Journal of Medical Ethics 50 (2): 126–138.
Beauchamp T.L., Childress J.F. (1977/2012), Principles of Biomedical Ethics, 7th ed., Oxford University Press, New York.
Buchanan D.R. (2008), “Autonomy, Paternalism, and Justice: Ethical Priorities in Public Health,” American Journal of Public Health 98(1): 15–21.
Childress J.F., Faden R.R., Gaare R.D., Gostin L.O., Kahn J., Bonnie R.J., Kass N.E., Mastroianni A.C., Moreno J.D., Nieburg P. (2002), “Public Health Ethics: Mapping the Terrain,” Journal of Law, Medicine & Ethics 30 (2): 170–178.
Cohen A.F., van Gerven J., Garcia Burgos J., de Boer A., Foucher R.A.M., Flore H., Teitelbaum Z., van Eden W., Webb A., Cremers S. (2020), “COVID-19 Vaccines: The Importance of Transparency and Fact-Based Education,” British Journal of Clinical Pharmacology 86 (11): 2107–2110.
Emanuel E.J., Buchanan A., Chan S.Y., Fabre C., Halliday D., Heath J., Herzog L. et al. (2021), “What Are the Obligations of Pharmaceutical Companies in a Global Health Emergency?,” The Lancet 398 (10304): 1015–1020.
de Fine Licht J. (2011), “Do We Really Want to Know? The Potentially Negative Effect of Transparency in Decision Making on Perceived Legitimacy,” Scandinavian Political Studies 34 (3): 183–201.
Florini A. (2007), “Conclusion: Whither Transparency?,” [in:] The Right to Know: Transparency for an Open World, A. Florini (ed.), Columbia University Press, New York: 337-348.
Giubilini A. (2019), The Ethics of Vaccination, Springer International Publishing.
Giubilini A., Gur-Arie R., Jamrozik E. (2025), “Expertise, Disagreement, and Trust in Vaccine Science and Policy. The Importance of Transparency in a World of Experts,” Diametros 22 (82): 7–27.
Giubilini A., Savulescu J. (2019), “Vaccination, Risks, and Freedom: The Seat Belt Analogy,” Public Health Ethics 12 (3): 237–249.
Jamrozik E. (2022), “Public Health Ethics: Critiques of the ‘New Normal’,” Monash Bioethics Review 40 (1): 1–16.
Kraaijeveld S.R. (2020), “Vaccinating for Whom? Distinguishing between Self-Protective, Paternalistic, Altruistic and Indirect Vaccination,” Public Health Ethics 13(2): 190–200.
Kraaijeveld S.R., Gur-Arie R., Jamrozik E. (2024), “A Scalar Approach to Vaccination Ethics,” The Journal of Ethics 28 (1): 145–169.
Leonardelli M., Mele F., Marrone M., Germinario C.A., Tafuri S., Moscara L., Bianchi F.P., Stefanizzi P. (2023), “The Effects of the COVID-19 Pandemic on Vaccination Hesitancy: A Viewpoint,” Vaccines 11 (7): 1191.
Lewis J., Schüklenk U. (2022), “Principlist Pandemics: On Fraud Ethical Guidelines, and the Importance of Procedural Transparency,” [in:] Ethical Public Health Policy Within Pandemics: Theory and Practice in Ethical Pandemic Administration, M. Boylan (ed.), Springer International Publishing: 131–148.
Lowe A.E., Voo T.C., Lee L.M., Gillespie K.K.D., Feig C., Ferdinand A.O., Mohapatra S., Brett-Major D.M., Wynia M.K. (2022), “Uncertainty, Scarcity and Transparency: Public Health Ethics and Risk Communication in a Pandemic,” The Lancet Regional Health – Americas (16): 1–6.
Murdie A. (2022), “Hindsight is 2020: Lessons from the COVID-19 Pandemic for Future Human Rights Research,” Journal of Human Rights 21 (3): 354–364.
O’Malley P., Rainford J., Thompson A. (2009), “Transparency during Public Health Emergencies: From Rhetoric to Reality,” Bulletin of the World Health Organization 87 (8): 614–618.
Plaisance P.L. (2007), “Transparency: An Assessment of the Kantian Roots of a Key Element in Media Ethics Practice,” Journal of Mass Media Ethics 22 (2–3): 187–207.
Sapienza A., Falcone R. (2022), “The Role of Trust in COVID-19 Vaccine Acceptance: Considerations from a Systematic Review,” International Journal of Environmental Research and Public Health 20 (1): 665.
Savulescu J., Giubilini A., Danchin M. (2021), “Global Ethical Considerations Regarding Mandatory Vaccination in Children,” The Journal of Pediatrics (231): 10–16.
Tanveer S., Rowhani-Farid A., Hong K., Jefferson T., Doshi P. (2022), “Transparency of COVID-19 Vaccine Trials: Decisions without Data,” BMJ Evidence-Based Medicine
(4): 199–205.
Vickery J., Atkinson P., Lin L., Rubin O., Upshur R., Eng-Kiong Yeoh, Boyer C., Errett N.A. (2022), “Challenges to Evidence-Informed Decision-Making in the Context of Pandemics: Qualitative Study of COVID-19 Policy Advisor Perspectives,” BMJ Global Health 7 (4): 1-10.